Anders Bjorkman

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008
    Maru W Aregawi
    World Health Organization, Global Malaria Programme, 20 Avenue Appia 1211 Geneva 27, Switzerland
    Malar J 10:46. 2011
  2. ncbi Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent
    R H Behrens
    Hospital for Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Malar J 5:7. 2006
  3. ncbi System effectiveness of a targeted free mass distribution of long lasting insecticidal nets in Zanzibar, Tanzania
    Netta Beer
    Division of Global Health IHCAR, Department of Public Health Sciences, Karolinska Institutet, 171 77 Stockholm, Sweden
    Malar J 9:173. 2010
  4. ncbi Public health impact of drug resistant Plasmodium falciparum malaria
    Anders Bjorkman
    Malaria Research Unit M9 02, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Solna 17176, Stockholm, Sweden
    Acta Trop 94:163-9. 2005
  5. ncbi Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania
    Andreas Martensson
    Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Stockholm 17176, Sweden
    J Infect Dis 195:597-601. 2007
  6. ncbi Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance
    Maria Isabel Veiga
    Malaria Research Lab, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 6:e20212. 2011
  7. ncbi In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa
    Christin Sisowath
    Infectious Diseases Unit, Department of Medicine and Karolinska Institutet, Stockholm, Sweden
    J Infect Dis 199:750-7. 2009
  8. ncbi The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
    Christin Sisowath
    Malaria Research Unit, Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    Trop Med Int Health 12:736-42. 2007
  9. ncbi Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa
    Sabina Dahlström
    Malaria Research, Karolinska Institutet, Stockholm, Sweden
    J Infect Dis 200:1456-64. 2009
  10. ncbi Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes
    Elisabeth Hugosson
    Malaria Research Unit M9, Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, 17176 Stockholm, Sweden
    Acta Trop 99:75-82. 2006

Collaborators

Detail Information

Publications34

  1. ncbi Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008
    Maru W Aregawi
    World Health Organization, Global Malaria Programme, 20 Avenue Appia 1211 Geneva 27, Switzerland
    Malar J 10:46. 2011
    ..The impact of the scale-up of insecticide-treated nets (ITN), indoor-residual spraying (IRS) and artemisinin-combination therapy (ACT) combined on malaria burden was assessed at six out of seven in-patient health facilities...
  2. ncbi Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent
    R H Behrens
    Hospital for Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Malar J 5:7. 2006
    ..The group recommended non-selective prescribing of chemoprophylaxis for visitors to India, Pakistan, Bangladesh and Sri Lanka should be dropped...
  3. ncbi System effectiveness of a targeted free mass distribution of long lasting insecticidal nets in Zanzibar, Tanzania
    Netta Beer
    Division of Global Health IHCAR, Department of Public Health Sciences, Karolinska Institutet, 171 77 Stockholm, Sweden
    Malar J 9:173. 2010
    ..The outcomes of this distribution among children under five were evaluated, four to nine months after implementation...
  4. ncbi Public health impact of drug resistant Plasmodium falciparum malaria
    Anders Bjorkman
    Malaria Research Unit M9 02, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Solna 17176, Stockholm, Sweden
    Acta Trop 94:163-9. 2005
    ..Early switch to artemisinin based combination therapy (ACT) represents such a critical and urgent strategy...
  5. ncbi Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania
    Andreas Martensson
    Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Stockholm 17176, Sweden
    J Infect Dis 195:597-601. 2007
    ..Interpretation of PCR-adjusted results will significantly depend on methodology...
  6. ncbi Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance
    Maria Isabel Veiga
    Malaria Research Lab, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 6:e20212. 2011
    ..Our work unveils new candidate markers of P. falciparum multidrug resistance in vitro, while contributing to the understanding of subjacent genetic complexity, essential for future evidence-based drug policy decisions...
  7. ncbi In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa
    Christin Sisowath
    Infectious Diseases Unit, Department of Medicine and Karolinska Institutet, Stockholm, Sweden
    J Infect Dis 199:750-7. 2009
    ..Identification of drug-specific parasite determinants that contribute to treatment failures will provide important tools for the detection and surveillance of AL resistance...
  8. ncbi The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
    Christin Sisowath
    Malaria Research Unit, Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    Trop Med Int Health 12:736-42. 2007
    ..e. pfmdr1 gene amplification, pfmdr1 Y184F, S1034C, N1042D, D1246Y, pfcrt S163R and PfATP6 S769N...
  9. ncbi Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa
    Sabina Dahlström
    Malaria Research, Karolinska Institutet, Stockholm, Sweden
    J Infect Dis 200:1456-64. 2009
    ..Our data suggest for the first time, to our knowledge, the involvement of pfMRP1 in P. falciparum in vivo response to ACT...
  10. ncbi Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes
    Elisabeth Hugosson
    Malaria Research Unit M9, Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, 17176 Stockholm, Sweden
    Acta Trop 99:75-82. 2006
    ..Alternative mechanisms for antipyretic effects and associations between fever and cytokine levels during uncomplicated P. falciparum malaria are therefore discussed...
  11. ncbi Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania
    Andreas Martensson
    Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Clin Infect Dis 41:1079-86. 2005
    ..Children who were 9-59 months of age and who weighted > or =9 kg were randomly assigned to receive either ASAQ or AL for 3 days in standard doses. Intention-to-treat analyses were performed...
  12. ncbi Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment
    Sabina Dahlström
    Malaria Research, Infectious Diseases Unit, Department of Medicine, Karolinska Institutet, Retzius väg 10, plan 5, 171 77 Stockholm, Sweden
    Antimicrob Agents Chemother 53:2553-6. 2009
    ..falciparum multidrug resistance protein homologue in the antimalarial activity of SP. Moreover, they add to the growing evidence of the potential importance of Pfmrp1 in antimalarial drug resistance...
  13. ncbi Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6)
    Sabina Dahlström
    Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Infect Genet Evol 8:340-5. 2008
    ..In conclusion our findings show that PfATP6 is a more diverse gene than previously demonstrated. This natural variation may constitute a starting ground for artemisinin-driven progressive selection of resistant parasites...
  14. ncbi Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial
    Billy E Ngasala
    Malaria Research, Infectious Diseases Unit, Department of Medicine Solna, Karolinska University Hospital, Stockholm, Sweden
    Clin Infect Dis 52:873-82. 2011
    ....
  15. ncbi Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa
    Gabrielle Holmgren
    Malaria Research Laboratory, Unit of Infectious Diseases, Division of Medicine, Karolinska Institute, Stockholm, Sweden
    Infect Genet Evol 7:562-9. 2007
    ..However, treatment failure rate and spread of pfmdr1 SNPs may remain at a low level because of the suggested opposite selection by ART and the pharmacodynamic advantages with ACT...
  16. ncbi In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil
    Mita M Thapar
    Department of Medicine, Infectious Diseases Unit, Malaria Research Laboratory, M9 02, Karolinska University Hospital, Karolinska Institute, SE 171 76 Stockholm, Sweden
    Trans R Soc Trop Med Hyg 99:62-70. 2005
    ..The baseline susceptibilities of the parasites to individual drugs were similar before and after recrudescence in all experiments...
  17. ncbi Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania
    Netta Beer
    Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
    Trop Med Int Health 14:766-74. 2009
    ..To estimate caretaker adherence to co-blistered, but not co-formulated, artesunate-amodiaquine (AsAq) for uncomplicated malaria and identify factors associated with caretaker adherence...
  18. ncbi Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y
    Gabrielle Holmgren
    Malaria Research Laboratory, Unit of Infectious Diseases, Department of Medicine, Karolinska Institute, Karolinska University Hospital, M9 02, 17176 Stockholm, Sweden
    Infect Genet Evol 6:309-14. 2006
    ..020). pfmdr1 86Y was also selected for, but only in recrudescent infections (p=0.048). The study showed high prevalence of AQ resistant parasites in vivo, which appeared to be associated to pfcrt 76T and pfmdr1 86Y...
  19. ncbi Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression
    Maria Isabel Veiga
    Malaria Research Lab, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 5:e12408. 2010
    ..However, cellular mechanisms related with metabolic activity have also been seen in eukaryotic systems, e.g. cancer cells. Recent observations suggest that such mechanism may occur in P. falciparum...
  20. ncbi In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
    Christin Sisowath
    Malaria Research Laboratory, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    J Infect Dis 191:1014-7. 2005
    ..This points to 86N as a potential marker of lumefantrine resistance in vivo, while suggesting that Coartem is not robust enough to avoid selection of resistance-associated mutations in some malarial settings...
  21. ncbi Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya
    Gabrielle Holmgren
    Malaria Research Unit, Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Stockholm, Sweden
    Trop Med Int Health 11:1808-12. 2006
    ..Our aim was to determine the current prevalence of pfmdr1 gene amplifications and a possible association between pfmdr1 gene copy number and amodiaquine treatment outcome in Kenya...
  22. ncbi Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar
    Achuyt Bhattarai
    Infectious Diseases Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS Med 4:e309. 2007
    ..We investigated temporal trends in Plasmodium falciparum prevalence and malaria-related health parameters following the implementation of these two malaria control interventions in Zanzibar...
  23. ncbi Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
    Eleonor C Saulo
    Malaria Research Unit M9, Division of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
    Malar J 7:227. 2008
    ..Socio-economic factors associated with WTP and expectations on anti-malaria drugs, including ACT, were also explored...
  24. ncbi Impact of training in clinical and microscopy diagnosis of childhood malaria on antimalarial drug prescription and health outcome at primary health care level in Tanzania: a randomized controlled trial
    Billy Ngasala
    Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    Malar J 7:199. 2008
    ..The impact of microscopy-based versus clinical-based diagnosis of childhood malaria was assessed at primary health care (PHC) facilities using a cluster randomized controlled training intervention trial...
  25. ncbi Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria
    Anja M Carlsson
    Infectious Diseases Unit, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Retzius väg 10, S 171 77 Stockholm, Sweden
    Malar J 10:380. 2011
    ..This study aimed to explore Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment with artemisinin-based combination therapy in children with clinical malaria in a high transmission area in Africa...
  26. ncbi Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment
    Anna Farnert
    Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Am J Trop Med Hyg 73:204-6. 2005
    ..The genotypes detected in one pre-treatment sample thus appear to reflect the parasite subpopulations of the clinical malaria infection during the following days, and additional sampling does not provide any additional information...
  27. ncbi Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa
    Pedro Eduardo Ferreira
    Malaria Research Laboratory, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Ther Drug Monit 30:10-5. 2008
    ..Ten (10.1%) subjects were predicted to be low metabolizers simultaneously for CYP3A4 and CYP3A5. This fraction of the population is suggested to be under higher exposure to certain antimalarials, including lumefantrine and quinine...
  28. ncbi Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria
    Elisabeth Hugosson
    Malaria Research Unit, Division of Infectious Diseases, Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden
    Am J Trop Med Hyg 69:366-71. 2003
    ..001) and similarly in the four treatment groups between days 0, 2, and 3. Thus, the addition of chloroquine or paracetamol to SP improved the clinical outcome, but did not affect the parasitologic response or antibody production...
  29. ncbi Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro
    Mita M Thapar
    Unit of Infectious Diseases, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    Trans R Soc Trop Med Hyg 97:331-7. 2003
    ..We conclude that the effectiveness of Malarone is due to the synergism between atovaquone and proguanil and may not require the presence of cycloguanil...
  30. ncbi Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America
    Irina T Jovel
    Malaria Research Laboratory, Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital Karolinska Institutet, Retzius väg 10, 171 77 Stockholm, Sweden
    Malar J 10:376. 2011
    ..The aim of this study was to determine the proportion of resistance associated genetic polymorphisms in P. falciparum and P. vivax collected in Honduras...
  31. ncbi HIV-infected African parents living in Stockholm, Sweden: disclosure and planning for their children's future
    Ann Sofie Asander
    Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Health Soc Work 34:107-15. 2009
    ..This study highlights the low HIV-disclosure rate to children of HIV-infected African immigrant parents and the importance of support from social workers...
  32. ncbi Malaria associated anaemia, drug resistance and antimalarial combination therapy
    Anders Bjorkman
    Division of Infectious Diseases, Department of Medicine, Karolinska Hospital, SE 17176 Stockholm, Sweden
    Int J Parasitol 32:1637-43. 2002
    ....
  33. ncbi Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis
    Anna Farnert
    Department of Medicine, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
    Am J Trop Med Hyg 66:487-91. 2002
    ..Chemoprophylaxis reduces the number of infecting clones and selects for resistant parasites as shown for proguanil through mutations in the dhfr gene...
  34. ncbi False-reactive microbiologic screening test results in Swedish blood donors-how big is the problem? A survey among blood centers and deferred donors
    Elsa Tynell
    Department of Medicine, Infectious Diseases Unit, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
    Transfusion 47:80-9. 2007
    ....